SCHEMBL3394059

SCHEMBL3394059

c1c[nH]c(C2CC(c3ncc[nH]3)CC(c3ncc[nH]3)C2)n1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADRA1A P35348 7/20 0.59
NISCH Q9Y2I1 1/20 0.41
ADRA2A P08913 3/20 0.40
ADRA1D P25100 1/20 0.40
ADRA1B P35368 1/20 0.40
HTR2B P41595 4/20 0.39
ALDH1A1 P00352 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
ALOX15 P16050 1/20 0.34
CHRNA1 P02708 1/20 0.33
ESR1 P03372 1/20 0.33
CHRNG P07510 1/20 0.33
CHRNB1 P11230 1/20 0.33
CHRNB2 P17787 1/20 0.33
CHRNA5 P30532 1/20 0.33
CHRNB4 P30926 1/20 0.33
CHRNA3 P32297 1/20 0.33
CHRNA7 P36544 1/20 0.33
CHRNA4 P43681 1/20 0.33
HTR3A P46098 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17950210 0.87 ADRA1A (0.52) ADRA1ANISCHADRA2AADRA1DADRA1B
SCHEMBL21573835 0.87 ADRA1A (0.52) ADRA1ANISCHADRA2AADRA1DADRA1B
SCHEMBL196337 0.85
Hydrochloric Acid SCHEMBL17941980 0.85 ADRA1A (0.50) ADRA1ANISCHADRA2AADRA1DADRA1B
Hydrochloric Acid SCHEMBL17941981 0.85 ADRA1A (0.50) ADRA1ANISCHADRA2AADRA1DADRA1B
SCHEMBL16512331 0.83 ADRA1A (0.49) ADRA1ANISCHADRA2AADRA1DADRA1B
SCHEMBL16577403 0.82 ADRA1A (0.47) ADRA1ANISCHADRA2AADRA1DADRA1B
SCHEMBL1494449 0.81
SCHEMBL1299173 0.81
SCHEMBL184451 0.81 ADRA1A (0.55) ADRA1ANISCHADRA2AADRA1DADRA1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8716472-B2 Tripodal cyclohexane derivatives and their use as carbohydrate receptors UNIVERSITY OF ROCHESTER (US) 2014-05-06 US claimed
US-20100041568-A1 TRIPODAL CYCLOHEXANE DERIVATIVES AND THEIR USE AS CARBOHYDRATE RECEPTORS UNIVERSITY OF ROCHESTER (US) 2010-02-18 US claimed
US-8716472-B2 Tripodal cyclohexane derivatives and their use as carbohydrate receptors UNIVERSITY OF ROCHESTER (US) 2014-05-06 US disclosed
US-20100041568-A1 TRIPODAL CYCLOHEXANE DERIVATIVES AND THEIR USE AS CARBOHYDRATE RECEPTORS UNIVERSITY OF ROCHESTER (US) 2010-02-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100041568-A1 TRIPODAL CYCLOHEXANE DERIVATIVES AND THEIR USE AS CARBOHYDRATE RECEPTORS CA14, HCAR1, CCKAR ADRA1A 3491/4885NISCH 762/4885ADRA2A 3726/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.